Viatris stock price forecast institutional research projects the

Institutional research projects the Viatris stock price forecast to maintain a tight range before a potential breakout following regulatory updates in late With operations in more than 165 countries, Viatris Inc. (NASDAQ:VTRS) is a multifaceted international healthcare organization with its headquarters located in Canonsburg, Pennsylvania. In important therapeutic areas like cardiovascular, central nervous system, infectious diseases, and oncology, it provides a broad selection of prescription brands, generics, complicated generics, and biosimilars. The company has a robust worldwide distribution network that includes retail and institutional pharmacies, e-commerce platforms, and specialized channels, and it has a portfolio of well-known products like EpiPen, Lipitor, Celebrex, and Viagra. Find out what Retail is Buying with our Retail Ownership and Funds Flow Leaderboard -> Economic indicators suggest Viatris stock price forecast could outperform broader pharma benchmarks if FDA approvals for pipeline products stay on schedule.